
Syneos Health SYNH
Quartalsbericht 2023-Q1
hinzugefügt 10.05.2023
Syneos Health DSO 2011-2026 | SYNH
DSO Jährlich Syneos Health
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 111 | 102 | 104 | 139 | 87.3 | 77.7 | 76.9 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 139 | 76.9 | 99.7 |
DSO Vierteljährlich Syneos Health
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | 30.7 | - | 59.9 | 58.6 | 59.2 | - | 59.6 | 62 | 59.2 | 78.2 | 71.3 | 96.9 | 47.7 | - | 43 | 45.9 | 40.8 | - | 41.3 | 42.8 | 42.6 | - | 39.8 | 41.6 | 44.5 | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 96.9 | 30.7 | 53.3 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | ||
|
Agilent Technologies
A
|
63.8 | $ 115.39 | -1.31 % | $ 35.1 B | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
63.7 | $ 1.16 | -1.69 % | $ 6.32 M | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 16.69 | -6.86 % | $ 889 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Burning Rock Biotech Limited
BNR
|
31.7 | $ 16.25 | 0.06 % | $ 175 M | ||
|
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | ||
|
Co-Diagnostics
CODX
|
94.7 | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
49.2 | $ 23.43 | -6.99 % | $ 651 M | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 175.55 | 0.27 % | $ 8.7 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
55.3 | $ 192.99 | -1.63 % | $ 138 B | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
66.9 | $ 2.3 | 16.02 % | $ 10.2 M | ||
|
Illumina
ILMN
|
61.3 | $ 123.67 | -3.38 % | $ 19.7 B | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 15.02 | -5.12 % | $ 454 M | ||
|
Guardant Health
GH
|
46.1 | $ 87.17 | -6.11 % | $ 10.9 B | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
275 | $ 2.74 | 0.37 % | $ 88.9 K | ||
|
Biomerica
BMRA
|
57.7 | $ 2.2 | 2.33 % | $ 5.05 M | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 106.7 | 0.15 % | $ 8.8 B | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 273.26 | -0.53 % | $ 22.7 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 501.5 | -3.68 % | $ 14.5 B | ||
|
Lantheus Holdings
LNTH
|
80.5 | $ 81.43 | 1.75 % | $ 5.5 B | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Myriad Genetics
MYGN
|
52.3 | $ 4.44 | -6.92 % | $ 411 M | ||
|
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 197.82 | -0.5 % | $ 22 B | ||
|
NeoGenomics
NEO
|
77.7 | $ 7.94 | -3.38 % | $ 1.02 B | ||
|
Neogen Corporation
NEOG
|
66.6 | $ 10.04 | -2.95 % | $ 2.18 B | ||
|
ENDRA Life Sciences
NDRA
|
7.11 | $ 5.31 | 2.71 % | $ 4.18 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 17.05 | -1.22 % | $ 382 M | ||
|
Natera
NTRA
|
81.5 | $ 203.0 | -3.71 % | $ 20 B | ||
|
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M | ||
|
Organovo Holdings
ONVO
|
79.8 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M |